Curonix LLC, a leader in non-opioid neuromodulation therapies for the treatment of chronic pain, today announced the publication of its landmark prospective, multi-center, randomized, FDA-approved IDE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback